PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.\', \'Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.\', \'Clinic for Internal Medicine, Uster Hospital, Uster, Switzerland.\', \'Department of Medicine, Limmattal Hospital, Schlieren, Switzerland.\', \'Clinic for Internal Medicine, City Hospital Triemli Zurich, Zurich, Switzerland.\', \'Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. onur.boyman@uzh.ch.\', \'Faculty of Medicine, University of Zurich, Zurich, Switzerland. onur.boyman@uzh.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-27797-1
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35078982
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all